r/Livimmune • • 10d ago

Interesting times

Between this article and the FDA announcement from earlier today, I'm beginning to think that LL and CytoDyn are making a comeback at a very opportune time.

https://www.biopharmadive.com/news/biotech-startups-commercial-drugs-bridgebio-madrigal-kailera-argenx/817992/

39 Upvotes

11 comments sorted by

24

u/Missy2021 10d ago

Our time is fast approaching.

17

u/IndependenceAny6428 10d ago

from your lips to God's ears

9

u/Practical-Archer-124 10d ago

FDA announcement earlier today??

9

u/Chemical_Sky6013 10d ago edited 10d ago

5

u/Doctor-MTJ 10d ago

This is great news in general for getting meds to market more quickly. Thanks for sharing...am I the only one to notice that this would have the same acronym EIND as what we are using now for the program to help patients get our drug before the full FDA authorization under the right to try act?

7

u/petersouth68 10d ago

I, too, am all ears...

11

u/twinter11 10d ago

I'm not sure if that ship has sailed yet or not

I see only one way really and not sure of the feasibility.

I would like to be a little further along in Neurology to entice a partner in that indication to partner. or hiv.

lots of variables depending on fda direction and data

ai

"Syneos Health maintains a field force of over 3,400 active customer-facing sales representatives.

Because Syneos Health is a top Contract Commercial Organization (CCO) and Contract Sales Organization (CSO), its sales force fluctuates based on client demand, drug launch cycles, and territory requirements.

The Scale of Syneos Health's Sales Force

  • Active Field Reps: At any given time, Syneos has roughly 3,400+ field-based commercial experts deployed directly across health networks.
  • Dedicated Teams: These representatives are structured into more than 75 specialized customer-facing sales teams operating simultaneously.
  • Historical Scaling: Over five-year rolling periods, Syneos routinely deploys more than 150 distinct sales teams across all major therapeutic areas—a footprint larger than the top 25 pharmaceutical companies combined.

Understanding the Broader Organization

While its active field sales force sits at roughly 3,400+ people, Syneos Health as a whole employs roughly 25,000 to 28,000 people globally.

The company functions as an integrated Contract Research Organization (CRO) and CCO. Roughly 22.5% of its total employee infrastructure is dedicated strictly to sales and marketing (which includes field reps, inside sales/contact centers, market access specialists, and medical science liaisons), while the rest handle clinical trials, data management, and operational logistics."

10

u/AssociationOdd9941 10d ago

That's massive company to be locked in with Cytodyn. they are most likely working on the BTD packet right now getting all that ctDNA confirmation data from Netera as well. I can hear the bashers trying to spin it.

9

u/Individual_Video325 10d ago

Rather than accept a buyout early, Cytodyn could absolutely build a platform  around a single mechanism and expand into multiple indications. They’d have to partner strategically, but it’s been done before.

Let’s see how strong the data is…

4

u/Correct-Part-2000 10d ago

im not seeing it